<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
      <journal-title>American Journal of Human Genetics</journal-title>
      <issn pub-type="ppub">0002-9297</issn>
      <issn pub-type="epub">1537-6605</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19463981</article-id>
      <article-id pub-id-type="pmc">2694978</article-id>
      <article-id pub-id-type="publisher-id">AJHG397</article-id>
      <article-id pub-id-type="doi">10.1016/j.ajhg.2009.04.020</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutations in <italic>NDUFAF3</italic> (<italic>C3ORF60</italic>), Encoding an NDUFAF4 (C6ORF66)-Interacting Complex I Assembly Protein, Cause Fatal Neonatal Mitochondrial Disease</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Saada</surname>
            <given-names>Ann</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vogel</surname>
            <given-names>Rutger O.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hoefs</surname>
            <given-names>Saskia J.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van den Brand</surname>
            <given-names>Mari&#xEB;l A.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wessels</surname>
            <given-names>Hans J.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Willems</surname>
            <given-names>Peter H.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Venselaar</surname>
            <given-names>Hanka</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shaag</surname>
            <given-names>Avraham</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barghuti</surname>
            <given-names>Flora</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reish</surname>
            <given-names>Orit</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shohat</surname>
            <given-names>Mordechai</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huynen</surname>
            <given-names>Martijn A.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Smeitink</surname>
            <given-names>Jan A.M.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van den Heuvel</surname>
            <given-names>Lambert P.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nijtmans</surname>
            <given-names>Leo G.</given-names>
          </name>
          <email>l.nijtmans@cukz.umcn.nl</email>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="cor1" ref-type="corresp">&#x2217;</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <addr-line><sup>1</sup>Metabolic Disease Unit, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel</addr-line>
      </aff>
      <aff id="aff2">
        <addr-line><sup>2</sup>Nijmegen Centre for Mitochondrial Disorders, Department of Pediatrics, Radboud University Nijmegen Medical Centre, Geert Grooteplein 10, 6500 HB, Nijmegen, The Netherlands</addr-line>
      </aff>
      <aff id="aff3">
        <addr-line><sup>3</sup>Nijmegen Centre for Mitochondrial Disorders, Department of Membrane Biochemistry, Radboud University Nijmegen Medical Centre, Geert Grooteplein 10, 6500 HB, Nijmegen, The Netherlands</addr-line>
      </aff>
      <aff id="aff4">
        <addr-line><sup>4</sup>Centre for Molecular and Biomolecular Informatics, Radboud University Nijmegen Medical Centre, Geert Grooteplein 10, 6500 HB, Nijmegen, The Netherlands</addr-line>
      </aff>
      <aff id="aff5">
        <addr-line><sup>5</sup>Al-Mustaqbal Hospital, P.O. Box 3921, Al-Bireh, Al-Balou, Ramallah 98700, Palestinian Authority</addr-line>
      </aff>
      <aff id="aff6">
        <addr-line><sup>6</sup>Genetics Institute, Assaf Harofeh Medical Center, Zerifin 70300, Israel</addr-line>
      </aff>
      <aff id="aff7">
        <addr-line><sup>7</sup>Department of Pediatrics and Genetics, The Raphael Recanati Genetic Institute, Rabin and Schneider Medical Centers, Petah Tikva 49100, Israel</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>&#x2217;</label>Corresponding author <email>l.nijtmans@cukz.umcn.nl</email></corresp>
        <fn id="fn1">
          <label>8</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>12</day>
        <month>6</month>
        <year>2009</year>
      </pub-date>
      <volume>84</volume>
      <issue>6</issue>
      <fpage>718</fpage>
      <lpage>727</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>2</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>24</day>
          <month>3</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>4</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2009 The American Society of Human Genetics. Published by Elsevier Ltd. All right reserved..</copyright-statement>
        <copyright-year>2009</copyright-year>
        <copyright-holder>The American Society of Human Genetics</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <p>Mitochondrial complex I deficiency is the most prevalent and least understood disorder of the oxidative phosphorylation system. The genetic cause of many cases of isolated complex I deficiency is unknown because of insufficient understanding of the complex I assembly process and the factors involved. We performed homozygosity mapping and gene sequencing to identify the genetic defect in five complex I-deficient patients from three different families. All patients harbored mutations in the <italic>NDUFAF3</italic> (<italic>C3ORF60</italic>) gene, of which the pathogenic nature was assessed by NDUFAF3-GFP baculovirus complementation in fibroblasts. We found that NDUFAF3 is a genuine mitochondrial complex I assembly protein that interacts with complex I subunits. Furthermore, we show that NDUFAF3 tightly interacts with NDUFAF4 (C6ORF66), a protein previously implicated in complex I deficiency. Additional gene conservation analysis links <italic>NDUFAF3</italic> to bacterial-membrane-insertion gene cluster <italic>SecF/SecD/YajC</italic> and to <italic>C8ORF38,</italic> also implicated in complex I deficiency. These data not only show that <italic>NDUFAF3</italic> mutations cause complex I deficiency but also relate different complex I disease genes by the close cooperation of their encoded proteins during the assembly process.</p>
      </abstract>
    </article-meta>
  </front>
  <floats-wrap>
    <fig id="fig1">
      <label>Figure&#xA0;1</label>
      <caption>
        <p>Genetic and Molecular Characterization of the c.229G&#x2192;C and c.365 G&#x2192;C Mutations</p>
        <p>(A) DNA samples of (a) a patient from family 1, the c.229 G&#x2192;C mutation indicated by an arrow, (b) an obligate heterozygote from family 1, (c) a control, (d) a patient from family 2, the c.365 G&#x2192;C mutation indicated by an arrow, (e) an obligate heterozygote from family 2, and (f) a control.</p>
        <p>(B) Conservation of the altered amino acids is shown via clustalW alignments. Asterisks (<sup>&#x2217;</sup>) indicate identical amino acids, colons (:) indicate conserved substitutions, and periods (.) indicate semiconserved substitutions.</p>
        <p>(C) Model of NDUFAF3 and the two mutations found in the patients. Middle panel: NDUFAF3 is shown in ribbon visualization and colored by secondary structure element (red = beta strand, blue = alpha helix, green = turn, cyan = coil). The positions of the two mutations found in patients are indicated by the arrows and colored yellow. Side panels: the R122P and G77R mutations shown in more detail. The protein is gray. The side chains of both the wild-type residue (green) and the mutant residue (red) are shown. Both mutations result in modifications at the same side of the protein.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Figure&#xA0;2</label>
      <caption>
        <p>Complementation of the Complex I Deficiency in Fibroblasts from Patients I-2 and II-1</p>
        <p>NI: not infected. Cox8: infected with GFP-tagged COX8 leader sequence. AF3: NDUFAF3-GFP infected.</p>
        <p>(A) SDS-PAGE immunodetections of GFP, NDUFS3, and NDUFA9.</p>
        <p>(B) Complex I in-gel activity (CI IGA) and BN-PAGE immunodetections of complex I (ND1), complex V (ATPase &#x3B1;), complex III (core II), complex IV (COX5A), and complex II (SDHA).</p>
        <p>(C) Enzymatic activities of complexes I (assayed as NADH-ubiquinone reductase), II, and IV after normalization to citrate synthase activity and untreated control (source data in <xref rid="app2" ref-type="sec">Table S2</xref>).</p>
        <p>(D) Two-dimensional BN-SDS immunodetections of NDUFS2 and ND1 in control and patient II-1 fibroblasts, before and after complementation (Compl.).</p>
        <p>(E and F) RNA interference-mediated knockdowns of NDUFAF3 and NDUFAF4 in HeLa cells. N: not treated. M: mock transfected. #1, #2: targets 1 and 2. (E) SDS-PAGE immunodetection of NDUFAF3, NDUFAF4, complex I subunits NDUFS3 and ND1, and control CII-70 kDa, after each knockdown.</p>
        <p>(F) BN-PAGE analysis of complex I in-gel activity (IGA) and immunodetection of complex I subunit NDUFA9, complex II-70 kDa, and complex III core II subunits.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Figure&#xA0;3</label>
      <caption>
        <p>Mitochondrial Localization and High-Molecular-Weight Associations of NDUFAF3</p>
        <p>(A) NDUFAF3-GFP, mitotracker, and Hoechst staining of NDUFAF3-GFP-inducible HEK293 Flp-in cells at different magnifications (a and b).</p>
        <p>(B) SDS-PAGE immunodetection analysis after subcellular and mitochondrial fractionation of HEK293 cells. Cyto: cytoplasm. Mito: mitochondria. After sonication of purified mitochondria, the pellet (P) contains membrane structures and the supernatant (S) represents the soluble fraction. Carbonate extraction unfolds membrane structures, releasing peripherally associated proteins to the supernatant.</p>
        <p>(C) Detection of NDUFS3-GFP (S3-GFP) and NDUFAF3-GFP (AF3-GFP) in native protein complexes via fluorscan of a 5%&#x2013;15% BN-PAGE gel. Previously identified complex I intermediates are indicated as by Vogel et&#xA0;al.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref></p>
        <p>(D) Two-dimensional BN- and SDS-PAGE immunodetection of NDUFAF3 and complex I subunits NDUFS2, NDUFS3, and ND1.</p>
        <p>(E) TAP identification of binding partners of NDUFAF3. SDS-PAGE immunodetections of proteins after NDUFS3-, NDUFAF3-, and NDUFAF4-TAP purifications indicated on the left. L: lysate. E: eluate. &#x201C;&#x2212;&#x201C;: without doxycycline. &#x201C;+&#x201D;: with 1 &#x3BC;g/ml doxycycline for 24 hr.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Figure&#xA0;4</label>
      <caption>
        <p>Inhibition of Translation and Proposed Role of NDUFAF3 during Complex I Assembly</p>
        <p>HEK293 cells were induced for NDUFS3-, NDUFAF3-, and NDUFAF4-GFP expression with and without prior chloramphenicol treatment (&#xB1; CAP) for 3 days.</p>
        <p>(A) Complex I in-gel activity (CI-IGA) assay.</p>
        <p>(B) SDS-PAGE fluorscan for GFP-tagged protein.</p>
        <p>(C) BN-PAGE immunodetection with antibody to GFP. Previously described NDUFS3-containing intermediates are indicated on the left as by Vogel et&#xA0;al.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> M: monomer. Accumulation is indicated with arrows, referring to subcomplexes of NDUFAF3 (AF3) and of NDUFAF4 (AF4).</p>
        <p>(D) The conserved gene cluster in alpha-proteobacteria that links orthologs of <italic>NDUFAF3</italic> to the bacterial preprotein translocase complex <italic>SecD/SecF/YajC</italic>, involved in targeting proteins to the membrane, and to <italic>CrtB</italic>, a phytoene/squalene synthetase of which the human ortholog <italic>C8ORF38</italic> has been implicated in complex I assembly.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> Green: proteins only observed in bacteria. Red: proteins observed in eukaryotes and bacteria.</p>
        <p>(E) Tentative model for the role of NDUFAF3 and NDUFAF4 during early complex I assembly. Subcomplex 2 is loosely associated to the mitochondrial inner membrane, as demonstrated by Dieteren et&#xA0;al.,<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> by an unknown factor (X). NDUFAF3 and NDUFAF4 are codependent, membrane localized, and present in subcomplex 3, which contains at least subunits NDUFS2 and NDUFS3, and possibly NDUFS8 and NDUFA5. This complex requires mitochondrial translation for progression to higher-molecular-weight subcomplexes. Without mitochondrial translation, NDUFAF3 no longer associates with subcomplex 3 and the complex, with NDUFAF4, accumulates. With mitochondrial translation, both proteins are present until subcomplex 6, close to finalization of holo-complex I. It is yet unknown which factors aid membrane insertion of mitochondrial translation products (indicated with Y). AF3: NDUFAF3. AF4: NDUFAF4. S3: subcomplex 3. X and Y: unknown factors. ND: ND subunits. Green structure: mitochondrial ribosome.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <table-wrap position="float" id="tbl1">
      <label>Table 1</label>
      <caption>
        <p>Complex I Activities in Patient Fibroblast and Muscle Mitochondria</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th>Patient</th>
            <th>Base Change</th>
            <th>Amino Acid Change</th>
            <th>Fibroblast<xref rid="tblfn1" ref-type="table-fn">a</xref></th>
            <th>Muscle<xref rid="tblfn1" ref-type="table-fn">a</xref></th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>Control</td>
            <td>-</td>
            <td>-</td>
            <td>217</td>
            <td>241</td>
          </tr>
          <tr>
            <td>I-1</td>
            <td>c.229 G&#x2192;C</td>
            <td>G77R</td>
            <td>n.d.<xref rid="tblfn2" ref-type="table-fn">b</xref></td>
            <td>23 (32%)</td>
          </tr>
          <tr>
            <td>I-2</td>
            <td>c.229 G&#x2192;C</td>
            <td>G77R</td>
            <td>16 (39%)</td>
            <td>49 (40%)</td>
          </tr>
          <tr>
            <td>I-3</td>
            <td>c.229 G&#x2192;C</td>
            <td>G77R</td>
            <td>n.d.<xref rid="tblfn2" ref-type="table-fn">b</xref></td>
            <td>n.d.<xref rid="tblfn2" ref-type="table-fn">b</xref></td>
          </tr>
          <tr>
            <td>II-1</td>
            <td>c.365 G&#x2192;C</td>
            <td>R122P</td>
            <td>5 (18%)</td>
            <td>60 (26%)</td>
          </tr>
          <tr>
            <td>III-1</td>
            <td>c.2 T&#x2192;C; c.365 G&#x2192;C</td>
            <td>M1T; R122P</td>
            <td>9 (33%)</td>
            <td>n.d.<xref rid="tblfn2" ref-type="table-fn">b</xref></td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn1">
          <label>a</label>
          <p>NADH:ubiquinone oxidoreducatase activity in nmol/min/mg (percentage of control, normalized to citrate synthase).</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tblfn2">
          <label>b</label>
          <p>Not determined.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-wrap>
</article>
</pmc-articleset>